Allarity Therapeutics Denmark ApS

CVR 38445928 · Private limited company (ApS) · Active · High risk

Allarity Therapeutics Denmark ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 5.3% over the next 12 months, which is 3.8 times the average for Danish companies. 9 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -2.5m and a net result of DKK 0. CEO: Jeffrey Stuart Ervin.

Bankruptcy risk for Allarity Therapeutics Denmark ApS

5.3%
probability of bankruptcy within 12 months
High risk

3.8 × the average (1.41%) · higher risk than 92% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Return on assets0%–5% · bankruptcy rate 5.8%0.66×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38445928
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
Venlighedsvej 1
2970 Hørsholm
Municipality
Rudersdal
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 100k
Audit opted out
Yes

Warning signs

Annual reports filed late2 of 9
Missing annual reportNo
Negative equityYes
Equity ratio-61,900.0%
Current ratio0%
Moves (last 2 years)0
CEO changes in total12
CEO's previous bankruptcies0
Other companies at the address3
Going-concern uncertaintyYes

Financials and key figures

Financial year202520242023
Gross profitDKK 0DKK 33kDKK 0
Net profitDKK 0DKK 174kDKK -1.2m
EquityDKK -2.5mDKK -2.5mDKK -2.7m
Total assetsDKK 4,000DKK 4,000DKK 6.6m
CashDKK 4,000DKK 4,000–
Short-term debtDKK 2.5mDKK 2.5m–
Tax owedDKK 397kDKK 397k–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025179
1 Jan 2024 – 31 Dec 2024177
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022181
1 Jan 2021 – 31 Dec 2021208 Late
1 Jan 2020 – 31 Dec 2020186 Late
1 Jan 2019 – 31 Dec 2019178
1 Jan 2018 – 31 Dec 2018163
13 Feb 2017 – 31 Dec 2017170

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOJeffrey Stuart ErvinCurrent
CEOThomas Henrik Jensen
CEOJens Erik Knudsen
CEOJames G. Cullem
CEOJoan Yvonne Brown
CEOSteen Meier Knudsen
CEOAlexander Epshinsky
BoardThomas Henrik Jensen
BoardPeter Buhl
BoardUlla Hald Buhl
Owner (100%)Allarity Acquisition Subsidiary, Inc.Current
Owner (20%)Allarity Therapeutics A/S
Owner (33%)Allarity Therapeutics Europe ApS
Owner (50%)SASS & LARSEN ApS
Owner (33%)SASS & LARSEN ApS
Owner (20%)Allarity Therapeutics A/S
Owner (50%)Allarity Therapeutics A/S
AuditorEY Godkendt Revisionspartnerselskab
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderAllarity Therapeutics A/SCurrent
FounderAllarity Therapeutics Europe ApSCurrent

The CEOs' other companies

Jens Erik Knudsen – 2 other companies

Steen Meier Knudsen – 4 other companies

Address history (0 moves)

Venlighedsvej 1, 2970 Hørsholm

Former names

Allarity Therapeutics Denmark ApS – now
OV-SPV2 ApS –

Other companies at the same address

Similar companies in Rudersdal

Questions and answers about Allarity Therapeutics Denmark ApS

Has Allarity Therapeutics Denmark ApS gone bankrupt?

No, Allarity Therapeutics Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Allarity Therapeutics Denmark ApS?

Our model estimates a bankruptcy risk of 5.3% over the next 12 months (high risk), which is 3.8 times the average for Danish companies.

Who is the CEO of Allarity Therapeutics Denmark ApS?

Jeffrey Stuart Ervin is the CEO of Allarity Therapeutics Denmark ApS.

When was Allarity Therapeutics Denmark ApS founded?

Allarity Therapeutics Denmark ApS was founded on 13 February 2017.

What is the equity of Allarity Therapeutics Denmark ApS?

Equity was DKK -2.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.